Computerized lesion measurement leverages sophisticated artificial intelligence software to evaluate both the quantity and volume of lesions present in MRI scans of the brain, as well as the cervical and spinal cord. These evaluations are conducted annually and facilitate the tracking of disease progression and the effectiveness of immunomodulatory drug treatments.